38 results
Page 2 of 2
8-K
EX-99.2
kzpmc0sy xhrk6lw
12 Nov 19
Reata Pharmaceuticals, Inc. Announces Third Quarter 2019 Financial Results and an Update on Development Programs
6:50am
8-K
EX-99.1
qmqklo4q8
15 Oct 19
Reata announces positive Topline results from the moxie Registrational trial of omaveloxolone in patients with friedreich’s ataxia
6:45am
8-K
EX-99.2
3n8ohs0w
15 Oct 19
Reata announces positive Topline results from the moxie Registrational trial of omaveloxolone in patients with friedreich’s ataxia
6:45am
8-K
EX-99.2
n1okormh
25 Sep 18
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl In Iga Nephropathy and Type 1 Diabetic Chronic Kidney Disease
7:05am
8-K
EX-99.1
zsir4mxm1
25 Sep 18
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl In Iga Nephropathy and Type 1 Diabetic Chronic Kidney Disease
7:05am
8-K
EX-99.1
6vrk ayip
23 Jul 18
Other Events
7:00am
8-K
EX-99.2
jebm7w pmh
23 Jul 18
Other Events
7:00am
8-K
EX-99.1
llh1my0qk 5g7r28rl
25 May 18
Other Events
6:03am
8-K
EX-99.3
9piugd ytgsjn46swl4q
25 May 18
Other Events
6:03am
8-K
EX-99.2
6cibhyhz
25 May 18
Other Events
6:03am
424B5
odn78sgvwp 5718plk
27 Jul 17
Prospectus supplement for primary offering
12:00am